Your browser doesn't support javascript.
loading
JAK2 as a molecular marker in myeloproliferative diseases.
Mata, R; Subirá, D; García-Raso, A; Llamas, P.
Affiliation
  • Mata R; Department of Hematology, Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, 28040 Madrid, Spain. rmserna6@hotmail.com
Cardiovasc Hematol Agents Med Chem ; 5(3): 198-203, 2007 Jul.
Article in En | MEDLINE | ID: mdl-17630945
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Janus Kinase 2 / Myeloproliferative Disorders Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Cardiovasc Hematol Agents Med Chem Journal subject: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA / HEMATOLOGIA / QUIMICA / QUIMICA CLINICA Year: 2007 Document type: Article Affiliation country: España
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Janus Kinase 2 / Myeloproliferative Disorders Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Cardiovasc Hematol Agents Med Chem Journal subject: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA / HEMATOLOGIA / QUIMICA / QUIMICA CLINICA Year: 2007 Document type: Article Affiliation country: España